Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipolytic Effects of GH in Human Subjects
NCT02782221Completed
- Sponsor
- Aarhus University
- Start
- May 2016
- Primary completion
- Sep 2016
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Randomised, double-blind trial in obesity comparing Growth hormone with Placebo (Pegvisomant) (2 arms). Primary endpoint: Lipolytic activity measured as area under the curve (AUC) for FFA at 1 year. Started May 2016; status: completed.
02
Drugs
somatropin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02782221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02782221.